Atria Investments Inc Has $255,000 Stock Position in Universal Health Services, Inc. $UHS

Atria Investments Inc grew its position in Universal Health Services, Inc. (NYSE:UHS) by 27.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,408 shares of the health services provider’s stock after purchasing an additional 307 shares during the period. Atria Investments Inc’s holdings in Universal Health Services were worth $255,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Universal Health Services during the second quarter worth about $87,373,000. AQR Capital Management LLC raised its position in shares of Universal Health Services by 57.8% during the first quarter. AQR Capital Management LLC now owns 931,355 shares of the health services provider’s stock worth $173,381,000 after acquiring an additional 340,966 shares during the last quarter. Ameriprise Financial Inc. lifted its holdings in Universal Health Services by 329.4% in the first quarter. Ameriprise Financial Inc. now owns 404,806 shares of the health services provider’s stock valued at $76,081,000 after buying an additional 310,531 shares during the period. Nuveen LLC bought a new stake in Universal Health Services in the first quarter worth approximately $25,555,000. Finally, Assenagon Asset Management S.A. grew its holdings in Universal Health Services by 119.5% in the second quarter. Assenagon Asset Management S.A. now owns 241,164 shares of the health services provider’s stock worth $43,687,000 after purchasing an additional 131,305 shares during the period. 86.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Universal Health Services

In related news, Director Warren J. Nimetz sold 3,817 shares of the stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $223.30, for a total transaction of $852,336.10. Following the completion of the transaction, the director owned 8,481 shares of the company’s stock, valued at approximately $1,893,807.30. This trade represents a 31.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Elliot J. Md Mba Sussman sold 965 shares of the business’s stock in a transaction on Wednesday, October 29th. The shares were sold at an average price of $225.70, for a total value of $217,800.50. Following the completion of the sale, the director owned 6,113 shares in the company, valued at $1,379,704.10. This represents a 13.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 16.40% of the company’s stock.

Analyst Ratings Changes

UHS has been the topic of a number of research analyst reports. UBS Group set a $231.00 target price on shares of Universal Health Services in a research note on Thursday, October 30th. Mizuho set a $242.00 price target on shares of Universal Health Services in a research note on Tuesday, October 28th. Morgan Stanley set a $233.00 target price on shares of Universal Health Services in a report on Wednesday, October 29th. The Goldman Sachs Group started coverage on shares of Universal Health Services in a research note on Tuesday, October 14th. They set a “neutral” rating and a $219.00 price objective for the company. Finally, Bank of America lowered shares of Universal Health Services from a “neutral” rating to an “underperform” rating and cut their target price for the company from $215.00 to $185.00 in a research note on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $233.20.

Universal Health Services Trading Up 1.7%

Shares of Universal Health Services stock opened at $228.28 on Thursday. Universal Health Services, Inc. has a twelve month low of $152.33 and a twelve month high of $231.37. The firm has a market capitalization of $14.53 billion, a PE ratio of 10.84, a P/E/G ratio of 0.80 and a beta of 1.33. The company has a current ratio of 1.03, a quick ratio of 1.19 and a debt-to-equity ratio of 0.55. The firm’s 50-day moving average price is $204.83 and its 200 day moving average price is $188.04.

Universal Health Services (NYSE:UHS) last released its quarterly earnings data on Tuesday, October 28th. The health services provider reported $5.69 earnings per share for the quarter, topping analysts’ consensus estimates of $4.66 by $1.03. Universal Health Services had a return on equity of 19.47% and a net margin of 8.09%.The company had revenue of $4.50 billion for the quarter, compared to analyst estimates of $4.32 billion. During the same quarter in the previous year, the company posted $3.71 earnings per share. The firm’s revenue for the quarter was up 13.4% compared to the same quarter last year. On average, sell-side analysts predict that Universal Health Services, Inc. will post 15.92 EPS for the current fiscal year.

Universal Health Services Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.